These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22751762)

  • 1. Dabigatran: uncharted waters and potential harms.
    Radecki RP
    Ann Intern Med; 2012 Jul; 157(1):66-8. PubMed ID: 22751762
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation, novel agents, and procedures: can we pardon the interruption?
    Garcia DA; Granger CB
    Circulation; 2012 Jul; 126(3):255-7. PubMed ID: 22700855
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran and postmarketing reports of bleeding.
    Southworth MR; Reichman ME; Unger EF
    N Engl J Med; 2013 Apr; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
    Sipahi I; Celik S; Tozun N
    JAMA Intern Med; 2014 Jan; 174(1):150-1. PubMed ID: 24247291
    [No Abstract]   [Full Text] [Related]  

  • 6. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamensky G; Parekh A; Reilly PA; Yusuf S; Connolly SJ
    Circulation; 2011 Jan; 123(2):131-6. PubMed ID: 21200007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications associated with oral anticoagulation therapy.
    Howard PK
    Adv Emerg Nurs J; 2013; 35(4):283-6. PubMed ID: 24176826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran "non-inferior" to warfarin, but only just.
    BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE; Lake JD
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract]   [Full Text] [Related]  

  • 10. Dabigatran and mechanical valves: less effective and more risky than warfarin.
    Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819180
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
    Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
    Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional events in the RE-LY trial.
    Connolly SJ; Wallentin L; Yusuf S
    N Engl J Med; 2014 Oct; 371(15):1464-5. PubMed ID: 25251519
    [No Abstract]   [Full Text] [Related]  

  • 14. Acutely injured patients on dabigatran.
    Cotton BA; McCarthy JJ; Holcomb JB
    N Engl J Med; 2011 Nov; 365(21):2039-40. PubMed ID: 22111735
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):264-8. PubMed ID: 21955008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial".
    Hjemdahl P; Johnsson H; Wallén NH
    Circulation; 2013 Mar; 127(11):e505. PubMed ID: 23509038
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by David et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) Randomized Trial".
    David JS; Piriou V; Albaladejo P
    Circulation; 2013 Mar; 127(11):e504. PubMed ID: 23509037
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.
    Healey JS; Eikelboom J; Yang S; Themeles E; Connolly SJ; Yusuf S; Douketis J; Wallentin L; Oldgren J; Heidbuchel H; Avezum A; Reilly P; Ezekowitz M
    Circulation; 2013 Mar; 127(11):e506. PubMed ID: 23646374
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV; Gage BF
    Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.